| Serial Number | 88760741 |
| Word Mark | ORIONIS |
| Filing Date | Wednesday, January 15, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, February 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Pseudo Mark | ORION IS |
| Goods and Services | Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Goods and Services | Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 22, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 22, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 22, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Orionis Biosciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Event Date | Event Description |
| Monday, February 12, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, February 12, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, October 27, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 27, 2023 | FINAL REFUSAL E-MAILED |
| Friday, October 27, 2023 | FINAL REFUSAL WRITTEN |
| Wednesday, September 27, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, January 31, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, June 1, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, October 29, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, April 23, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, August 10, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, August 10, 2020 | LETTER OF SUSPENSION E-MAILED |
| Monday, August 10, 2020 | SUSPENSION LETTER WRITTEN |
| Monday, July 20, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 20, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 20, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 25, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 25, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 25, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 24, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, January 22, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 18, 2020 | NEW APPLICATION ENTERED |